Clinical Research
Copyright ©The Author(s) 2003.
World J Gastroenterol. Dec 15, 2003; 9(12): 2796-2800
Published online Dec 15, 2003. doi: 10.3748/wjg.v9.i12.2796
Table 1 Relationship between clinical manifestations and pathological grading and staging of liver tissues
GroupsSymptom score + physical signsnInflammatory grading ( G ) (%)
Fibrosis staging (s) (%)
123401234
10~1+ no hepatomegaly and splenomegaly1546.74013.3033.326.74000
20~1+ hepatomegaly and splenomegaly1428.628.628.614.37.135.728.614.314.3
3~3+no hepatomegaly and splenomegaly2842.953.63.5014.35035.700
42~3 +hepatomegaly and splenomegaly4230.926.228.516.79.523.840.516.79.5
54+ no hepatomegaly and splenomegaly3243.72515.615.612.534.32515.612.5
64+ hepatomegaly and splenomegaly6923.321.734.815.92.9292915.923.2
P < 0.01P < 0.01
Table 2 Relationship between biochemical parameters and inflammatory grading and fibrosis staging
ParametersInflammatory (G) (%)
Fibrosis staging (s) (%)
1~21~31~42~32~43~40~10~20~30~41~21~31~42~32~43~4
RBCbbbaaaa
PLTbbb
ASTbbab
ALT
AST/ALT
GGTaabbbbbbbbb
Abbbbbb
A/Gbbbbbb
HAbbbbbbbbbbbbb
LN
7S-IVababaaa
PIIINPbb
AFPbbbbbbbbbbb
PT
Table 3 Serologic parameters for diagnosing liver fibrosis and cirrhosis
ParametersFibrosis (S0/S1~4)
Cirrhosis (S1~3/S4)
Specificity (%)Sensitivity (%)Accuracy (%)Specificity (%)Sensitivity (%)Accuracy (%)
HA94.4438.2643.5090.060.085.71
PIIINP16.6777.7172.078.024.070.28
LN55.2650.2950.1054.052.053.71
7S-IV50.2224.6751.093.2924.089.08
Table 4 Serologic parameters for diagnosing liver fibrosis and cirrhosis
ParametersFibrosis (S0/S1~4)
Cirrhosis (S1~3/S4)
Specificity (%)Sensitivity (%)Accuracy (%)Specificity (%)Sensitivity (%)Accuracy (%)
HA+7S-IV88.8937.9342.5089.9360.085.63
HA+PIIINP88.8942.8647.1090.060.085.71
HA+7S-IV+88.8947.1351.0489.9364.086.21
PIIINP+LN
HA+TIMP92.8638.2843.6790.2760.086.72
PGA+HA60.060.4460.4089.4166.6787.91
PGAA+HA70.062.6463.6789.4166.6787.91
PGA+7S-IV61.1250.2250.3190.5933.3386.80
PGAA+7S-IV60.048.2250.6792.9433.3389.0